Abstract
Background A 45-year-old woman with small-cell lung cancer presented to a hospital emergency department in an acute confusional state, with blurred vision and mild headache. Following progressively increasing lethargy, she subsequently became unresponsive to tactile and verbal stimuli. She had recently been started on chemotherapy with carboplatin and gemcitabine.
Investigations Physical examination, imaging studies including brain MRI, noncontrast brain CT scans and magnetic resonance angiography, continuous EEG monitoring, and cerebrospinal fluid analysis.
Diagnosis Posterior reversible leukoencephalopathy syndrome (PRES) related to chemotherapy, and nonconvulsive status epilepticus related to PRES.
Management Withholding of chemotherapeutic agents, and antiseizure therapy for the status epilepticus.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Hinchey J et al. (1996) A reversible posterior leukoencephalopathy syndrome. N Engl J Med. 334: 494–500
Kozak OS et al. (2007) Status epilepticus as initial manifestation of posterior reversible encephalopathy syndrome. Neurology 69: 894–897
Bhatt A et al. (2008) Periodic lateralized epileptiform discharges: an initial electrographic pattern in reversible posterior leukoencephalopathy syndrome. Neurol Neurochir Pol 42: 55–59
Bartynski WS (2008) Posterior reversible encephalopathy syndrome, part 1: fundamental imaging and clinical features. AJNR Am J Neuroradiol 29: 1036–1042
Bartynski WS and Boardman JF (2007) Distinct imaging patterns and lesion distribution in posterior reversible encephalopathy syndrome. AJNR Am J Neuroradiol 28: 1320–1327
Cooney MJ et al. (2000) Hypertensive encephalopathy: complication in children treated for myeloproliferative disorders—report of three cases. Radiology 214: 711–716
Shah-Khan FM et al. (2007) Reversible posterior leukoencephalopathy syndrome and anti-neoplastic agents: a review. Oncol Rev 1: 152–161
Bartynski WS (2008) Posterior reversible encephalopathy syndrome, part 2: controversies surrounding pathophysiology of vasogenic edema. AJNR Am J Neuroradiol 29: 1043–1049
Gerstner ER and Fine RL (2007) Increased permeability of the blood–brain barrier to chemotherapy in metastatic brain tumors: establishing a treatment paradigm. J Clin Oncol 25: 2306–2312
Thews O et al. (2008) Activity of drug efflux transporters in tumor cells under hypoxic conditions. Adv Exp Med Biol 614: 157–164
Sculier JP et al. (1987) Neurologic disorders in patients with small cell lung cancer. Cancer 60: 2275–2283
Euser AG et al. (2008) Magnesium sulphate treatment decreases blood–brain barrier permeability during acute hypertension in pregnant rats. Exp Physiol 93: 254–261
Rajasekhar A and George TJ Jr (2007) Gemcitabine-induced reversible posterior leukoencephalopathy syndrome: a case report and review of the literature. Oncologist 12: 1332–1335
Vieillot S et al. (2007) Reversible posterior leukoencephalopathy syndrome after carboplatin therapy. Ann Oncol 18: 608–609
Minami T et al. (1996) Detection of platinum in the brain of mice treated with cisplatin and subjected to short-term hypoxia. J Pharm Pharmacol 48: 505–509
Horbinski C et al. (2008) Reversible encephalopathy after cardiac transplantation: histologic evidence of endothelial activation, T-cell specific trafficking, and vascular endothelial growth factor expression. AJNR Am J Neuroradiol [10.3174/ajnr.A1311]
Shweiki D et al. (1992) Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359: 843–845
Henderson RD et al. (2003) Posterior leukoencephalopathy following intrathecal chemotherapy with MRA-documented vasospasm. Neurology 60: 326–328
Bartynski WS and Boardman JF (2008) Catheter angiography, MR angiography, and MR perfusion in posterior reversible encephalopathy syndrome. AJNR Am J Neuroradiol 29: 447–455
Connolly RM et al. (2007) Chemotherapy induced reversible posterior leukoencephalopathy syndrome. Lung Cancer 56: 459–463
Junna MR and Rabinstein AA (2007) Tacrolimus induced leukoencephalopathy presenting with status epilepticus and prolonged coma. J Neurol Neurosurg Psychiatry 78: 1410–1411
van Oosterhout AG et al. (1996) Neurologic disorders in 203 consecutive patients with small cell lung cancer. Results of a longitudinal study. Cancer 77: 1434–1441
Belogolovkin V et al. (2006) Postpartum eclampsia complicated by reversible cerebral herniation. Obstet Gynecol 107: 442–445
Glantz MJ et al. (1994) The radiographic diagnosis and treatment of paraneoplastic central nervous system disease. Cancer 73: 168–175
Savarese DM et al. (1996) Cerebral demyelination syndrome in a patient treated with 5-fluorouracil and levamisole. The use of thallium SPECT imaging to assist in noninvasive diagnosis—a case report. Cancer 77: 387–394
Schaefer PW et al. (1997) Diffusion-weighted imaging discriminates between cytotoxic and vasogenic edema in a patient with eclampsia. Stroke 28: 1082–1085
Acknowledgements
Désirée Lie, University of California, Irvine, CA, is the author of and is solely responsible for the content of the learning objectives, questions and answers of the Medscape-accredited continuing medical education activity associated with this article. Written consent for publication was obtained from the patient or their responsible relative.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Bhatt, A., Farooq, M., Majid, A. et al. Chemotherapy-related posterior reversible leukoencephalopathy syndrome. Nat Rev Neurol 5, 163–169 (2009). https://doi.org/10.1038/ncpneuro1045
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ncpneuro1045
This article is cited by
-
Imaging spectrum of central nervous system complications of hematopoietic stem cell and solid organ transplantation.
Neuroradiology (2017)
-
Posterior reversible encephalopathy syndrome in cancer patients: a single institution retrospective study
Journal of Neuro-Oncology (2016)
-
Posterior Reversible Encephalopathy Syndrome: A Neurologic Phenomenon in Cancer Patients
Current Oncology Reports (2014)
-
Reversible posterior leukoencephalopathy syndrome associated with mFOLFOX6 chemotherapy
International Cancer Conference Journal (2012)
-
Reversible Posterior Leukoencephalopathy Syndrome Associated with Concurrent Bevacizumab, Gemcitabine, and Oxaliplatin for Cholangiocarcinoma
Journal of Gastrointestinal Cancer (2012)